Skip to main content
Mobile
  • Finance, Accounting & Economics
  • Global Business Management
  • Management, Leadership & Organisation
  • Marketing & Sales
  • Strategy
  • Technology & Operations
HS Talks HS Talks
Subjects  
Search
  • Notifications
    Notifications

    No current notifications.

  • User
    Welcome Guest
    You have Limited Access The Business & Management Collection
    Login
    Get Assistance
    Login
    Forgot your password?
    Login via your organisation
    Login via Organisation
    Get Assistance
Finance, Accounting & Economics
Global Business Management
Management, Leadership & Organisation
Marketing & Sales
Strategy
Technology & Operations
Research paper

Maximising the value of a pharmaceutical line extension using discrete choice modelling, secondary data and market segmentation

Michael Latta and Melissa Clark
Applied Marketing Analytics: The Peer-Reviewed Journal, 2 (1), 84-91 (2016)
https://doi.org/10.69554/LWBV6606

Abstract

Pharmaceutical marketing is an industry that differs from consumer marketing in many ways. Pharmaceutical marketers must consider many factors when making product development choices. This study utilises a discrete choice model to make a recommendation for maximising the value of a cough syrup product line extension by an established pharmaceutical company, Celltech. Two cough syrups — Tussionex®, a hydrocodone polistirex extended release suspension product, and Delsym®, a dextromethorphan polistirex extended release suspension product — were already marketed by Celltech. Primary data in the form of a telephone survey of 160 primary care physicians and 140 paediatricians and secondary data from the IMS National Prescription Audit were utilised to inform the research process and generate tradeoff and cannibalisation analyses. Those analyses were done and FDA approval was obtained for the product (Codeprex®, a codeine polistirex extended release suspension product) in 2004, but the product was abandoned after Celltech was acquired by UCB-USA. The value of FDA-approved Codeprex™ was shown to be maximised by the tradeoff and cannibalisation analyses, but corporate strategy trumps applied marketing analytics in this case.

Keywords: pharmaceutical marketing; discrete choice model; physicians; product line extension; secondary data; market segmentation

The full article is available to subscribers to the journal.

Already a subscriber? Login or review other options.

Author's Biography

Michael Latta has held pharmaceutical marketing positions at AstraZeneca, Boehringer Mannheim, DuPont and Wyeth. He is currently a consultant to pharmaceutical and medical device companies and a professor of marketing at Coastal Carolina University, teaching and researching the use of statistics and marketing strategy at the Wall College of Business Administration in Conway, South Carolina. Michael has published applied research in Atlantic Marketing Journal, Quirk’s Marketing Research Review, Marketing News, Marketing to Health Systems and Alert! magazine, among others. He is a member of American Marketing Association, Marketing Research Association, American Statistical Association and American Association for the Advancement of Science. Michael’s PhD is in I/O psychology from Iowa State University.

Melissa Clark is an associate professor of marketing at Coastal Carolina University in Conway, South Carolina. She teaches and researches in social media marketing and has additional research interests in conscious capitalism, relationship marketing and pharmaceutical marketing. Melissa has published work in the Journal of Digital and Social Media Marketing, Journal of Retailing and Consumer Services and the Journal of Medical Marketing, among others. She is a member of the American Marketing Association and the Society for Marketing Advances. Melissa’s PhD in marketing is from the University of Mississippi.

Citation

Latta, Michael and Clark, Melissa (2016, February 1). Maximising the value of a pharmaceutical line extension using discrete choice modelling, secondary data and market segmentation. In the Applied Marketing Analytics: The Peer-Reviewed Journal, Volume 2, Issue 1. https://doi.org/10.69554/LWBV6606.

Options

  • Download PDF
  • Share this page
    Share This Article
    Messaging
    • Outlook
    • Gmail
    • Yahoo!
    • WhatsApp
    Social
    • Facebook
    • X
    • LinkedIn
    • VKontakte
    Permalink
cover image, Applied Marketing Analytics: The Peer-Reviewed Journal
Applied Marketing Analytics: The Peer-Reviewed Journal
Volume 2 / Issue 1
© Henry Stewart
Publications LLP

The Business & Management Collection

  • ISSN: 2059-7177
  • Contact Us
  • Request Free Trial
  • Recommend to Your Librarian
  • Subscription Information
  • Match Content
  • Share This Collection
  • Embed Options
  • View Quick Start Guide
  • Accessibility

Categories

  • Finance, Accounting & Economics
  • Global Business Management
  • Management, Leadership & Organisation
  • Marketing & Sales
  • Strategy
  • Technology & Operations

Librarian Information

  • General Information
  • MARC Records
  • Discovery Services
  • Onsite & Offsite Access
  • Federated (Shibboleth) Access
  • Usage Statistics
  • Promotional Materials
  • Testimonials

About Us

  • About HSTalks
  • Editors
  • Contact Information
  • About the Journals

HSTalks Home

Follow Us On:

HS Talks
  • Site Requirements
  • Copyright & Permissions
  • Terms
  • Privacy
  • Sitemap
© Copyright Henry Stewart Talks Ltd

Personal Account Required

To use this function, you need to be signed in with a personal account.

If you already have a personal account, please login here.

Otherwise you may sign up now for a personal account.

HS Talks

Cookies and Privacy

We use cookies, and similar tools, to improve the way this site functions, to track browsing patterns and enable marketing. For more information read our cookie policy and privacy policy.

Cookie Settings

How Cookies Are Used

Cookies are of the following types:

  • Essential to make the site function.
  • Used to analyse and improve visitor experience.

For more information see our Cookie Policy.

Some types of cookies can be disabled by you but doing so may adversely affect functionality. Please see below:

(always on)

If you block these cookies or set alerts in your browser parts of the website will not work.

Cookies that provide enhanced functionality and personalisation. If not allowed functionality may be impaired.

Cookies that count and track visits and on website activity enabling us to organise the website to optimise the experience of users. They may be blocked without immediate adverse effect.